159 related articles for article (PubMed ID: 33999136)
1. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Santella C; Bitton A; Filliter C; Bessissow T; Vutcovici M; Lakatos PL; Brassard P
Inflamm Bowel Dis; 2022 Feb; 28(2):176-182. PubMed ID: 33999136
[TBL] [Abstract][Full Text] [Related]
2. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
Côté-Daigneault J; Bessissow T; Nicolae MV; Nie R; Bitton A; Lakatos PL; Brassard P
Inflamm Bowel Dis; 2019 Apr; 25(5):914-918. PubMed ID: 30295818
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
Long MD; Martin C; Sandler RS; Kappelman MD
Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
[TBL] [Abstract][Full Text] [Related]
4. The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
Khan N; Trivedi C; Shah Y; Patel D; Lewis J; Yang YX
Inflamm Bowel Dis; 2018 May; 24(6):1274-1279. PubMed ID: 29522099
[TBL] [Abstract][Full Text] [Related]
5. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
[TBL] [Abstract][Full Text] [Related]
6. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea.
Chang K; Lee HS; Kim YJ; Kim SO; Kim SH; Lee SH; Song EM; Hwang SW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1928-1936.e2. PubMed ID: 29857150
[TBL] [Abstract][Full Text] [Related]
7. Incidence of herpes zoster in patients with inflammatory bowel disease.
Calm A; Calafat M; González-Muñoza C; Cañete F; Roig C; Mañosa M; García-Planella E; Domènech E
Gastroenterol Hepatol; 2024; 47(6):598-604. PubMed ID: 38316174
[TBL] [Abstract][Full Text] [Related]
8. Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
Khan N; Trivedi C; Kavani H; Lewis J; Yang YX
Inflamm Bowel Dis; 2019 Jan; 25(2):345-351. PubMed ID: 29982646
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.
Dai C; Jiang M; Huang YH
Inflamm Bowel Dis; 2021 Nov; 27(12):e156. PubMed ID: 34259845
[No Abstract] [Full Text] [Related]
10. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.
Gupta G; Lautenbach E; Lewis JD
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1483-90. PubMed ID: 17162240
[TBL] [Abstract][Full Text] [Related]
11. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
Khan N; Shah Y; Trivedi C; Lewis JD
Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
[TBL] [Abstract][Full Text] [Related]
12. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR
JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease.
Kochhar GS; Desai A; Caldera DO F; El Hachem S; Aoun E; Sandhu D; Mohan BP; Dulai PS; Farraye FA
Vaccine; 2021 Jul; 39(30):4199-4202. PubMed ID: 34140170
[TBL] [Abstract][Full Text] [Related]
14. Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Soh H; Chun J; Han K; Park S; Choi G; Kim J; Lee J; Im JP; Kim JS
Gut Liver; 2019 May; 13(3):333-341. PubMed ID: 30602222
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
[TBL] [Abstract][Full Text] [Related]
16. Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?
Nugent Z; Singh H; Targownik LE; Bernstein CN
Inflamm Bowel Dis; 2019 Feb; 25(3):532-540. PubMed ID: 30085137
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies.
Ning L; Liu R; Li S; Shan G; Du H; Zhang J; Chen W; Zhang F; Yu J; Xu G
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):219-227. PubMed ID: 31650411
[TBL] [Abstract][Full Text] [Related]
18. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A
JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331
[TBL] [Abstract][Full Text] [Related]
19. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
[TBL] [Abstract][Full Text] [Related]
20. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
Khan N; Trivedi C; Aberra F; Pernes T; Yang YX
J Crohns Colitis; 2022 Sep; 16(9):1505-1507. PubMed ID: 35350070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
